← Eichor
Study identifier: NCT06560905 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Preoperative Planning With PSMA-PET in Melanoma Surgery Trial

Condition: Malignant Melanoma  ·  Sponsor: Royal Marsden NHS Foundation Trust

PhasePhase 2
Planned participants16
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a non-randomised, single-centre Phase 2 study, investigating whether the diagnostic biomarker, prostate-specific membrane antigen (PSMA), can detect melanoma metastases using PSMA PET/ CT.

This description comes directly from the study's public registry record.

Talk to the study team

Reyhaneh Sadegh Zadeh  ·  020 7352 8171  ·  reyhaneh.sadeghzadeh@rmh.nhs.uk

Always discuss trial participation with your own doctor first.

Locations (1)

The Royal Marsden NHS Foundation TrustLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06560905